Artwork

Inhalt bereitgestellt von Roman Balmakov and The Epoch Times. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Roman Balmakov and The Epoch Times oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
Player FM - Podcast-App
Gehen Sie mit der App Player FM offline!

$6.5-Billion ‘Baby Powder-Cancer’ Settlement Proposal Pushed Forward by Johnson and Johnson | Facts Matter

11:36
 
Teilen
 

Manage episode 418286667 series 3327857
Inhalt bereitgestellt von Roman Balmakov and The Epoch Times. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Roman Balmakov and The Epoch Times oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
Headquartered in New Jersey, Johnson and Johnson is one of the largest pharmaceutical companies in the world. It’s also one of the handful of companies that made a windfall during the pandemic with their vaccine. In fact, the Janssen shot was making the company upwards of $740 million dollar per quarter—that was, of course, before the shot was pulled off the market due to an elevated risk of serious blood clots in vaccine recipients. However, having their vaccine pulled off the market might be the least of Johnson and Johnson’s financial worries. That’s because just yesterday, the company announced a willingness to pay $6.5 billion dollar in order to settle nearly all of the lawsuits in America claiming that their baby powder (and talcum powder products) caused people to develop cancer. Once enacted, this settlement will be the 4th largest in US history, right behind the $7.2 billion dollar that Enron had to pay after defrauding their shareholders.

🇺🇸 Epoch Times 25¢ Sale: https://ept.ms/RomanSale1 🇺🇸Roman's Special Offer👉 https://ept.ms/RomanSpecialOffer ⭕️ Support our fight for the truth👉 https://donorbox.org/facts_matter

  continue reading

250 Episoden

Artwork
iconTeilen
 
Manage episode 418286667 series 3327857
Inhalt bereitgestellt von Roman Balmakov and The Epoch Times. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von Roman Balmakov and The Epoch Times oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.
Headquartered in New Jersey, Johnson and Johnson is one of the largest pharmaceutical companies in the world. It’s also one of the handful of companies that made a windfall during the pandemic with their vaccine. In fact, the Janssen shot was making the company upwards of $740 million dollar per quarter—that was, of course, before the shot was pulled off the market due to an elevated risk of serious blood clots in vaccine recipients. However, having their vaccine pulled off the market might be the least of Johnson and Johnson’s financial worries. That’s because just yesterday, the company announced a willingness to pay $6.5 billion dollar in order to settle nearly all of the lawsuits in America claiming that their baby powder (and talcum powder products) caused people to develop cancer. Once enacted, this settlement will be the 4th largest in US history, right behind the $7.2 billion dollar that Enron had to pay after defrauding their shareholders.

🇺🇸 Epoch Times 25¢ Sale: https://ept.ms/RomanSale1 🇺🇸Roman's Special Offer👉 https://ept.ms/RomanSpecialOffer ⭕️ Support our fight for the truth👉 https://donorbox.org/facts_matter

  continue reading

250 Episoden

Alle Folgen

×
 
Loading …

Willkommen auf Player FM!

Player FM scannt gerade das Web nach Podcasts mit hoher Qualität, die du genießen kannst. Es ist die beste Podcast-App und funktioniert auf Android, iPhone und im Web. Melde dich an, um Abos geräteübergreifend zu synchronisieren.

 

Kurzanleitung